Utah Scientists Identify Arc Protein Driving Alzheimer’s Tau Spread in Mice

Q: A new therapy might trap Alzheimer's toxins. How soon could this halt the disease before it infects more brain cells?

Not soon. The approach is still at an early, preclinical stage, and there is no timeline yet for when it could be used in patients. The new study, published in *Cell*, shows in mice that toxic Tau spreads by hitching a ride in extracellular vesicles with the help of the Arc protein. When Arc was removed, Tau transfer between neurons fell by about 99%, strongly suggesting that blocking these Tau-carrying vesicles could slow or stop further spread to healthy brain cells. But researchers stress that this is not yet a treatment. Most of the work was done in mouse models, with supporting evidence from human brain tissue, and scientists say they are still far from developing a therapy for people. A major challenge is that Arc is not simply harmful: it also appears to protect stressed neurons early in disease by helping them expel excess Tau. That means any therapy would likely need to intercept toxic vesicles after they leave a sick cell, without disrupting Arc’s normal role in memory and synaptic function. In practical terms, even if the mechanism holds up in humans, a drug based on it would still need years of lab work, safety testing, and clinical trials. So the realistic answer is that this strategy is promising as a future way to slow Alzheimer’s progression, especially early on, but it is not expected to halt the disease in patients anytime soon.

3 articles · Updated · ScienceDaily · Jun 30

Cell-published mouse experiments found the brain protein Arc is essential for toxic Tau to move from diseased neurons into healthy ones, giving Alzheimer’s a newly identified route to spread.
Researchers showed Tau hitchhikes with Arc inside extracellular vesicles—tiny membrane-bound sacs that normally carry neuron-to-neuron signals—then seeds new Tau tangles after entering healthy cells.
Arc removal sharply cut Tau inside those vesicles and nearly halted transmission, but it also trapped toxic Tau in already damaged neurons, causing those cells to die faster.
Human brain tissue also contained vesicles carrying both Arc and Tau, suggesting the mechanism may extend beyond mice, though the team said any therapy remains far from clinical use.
The findings point to blocking Tau-containing vesicles from entering healthy neurons—rather than stopping Tau release entirely—as a possible way to slow further cognitive decline.

Sources

ScienceDaily9h ago

University of Utah Health Scientists Identify Arc Protein as Key to Alzheimer's Tau Spread

Neuroscience News9h ago

Arc Protein Found to Spread Toxic Tau in Alzheimer's - Neuroscience News

Diari ARA22h ago

The cellular 'hitchhiking' that could explain the advance of Alzheimer's

A new therapy might trap Alzheimer's toxins. How soon could this halt the disease before it infects more brain cells?

If a brain protein helps spread Alzheimer's like a virus, could antiviral-style drugs be the key to a cure?

Arc Protein Drives Tau Spread in Alzheimer’s: New Mechanism, Therapeutic Targets, and the Shift Beyond Amyloid

Overview

Recent research has revealed that the Arc protein, essential for memory and healthy brain function, plays a surprising role in the spread of Alzheimer’s disease. Normally, Arc helps neurons communicate by packaging itself into tiny sacs called extracellular vesicles (EVs). In Alzheimer’s, however, toxic tau proteins hitch a ride inside these Arc-containing EVs. This allows tau to move from diseased to healthy neurons, where it triggers new tau buildup and helps the disease spread through the brain. Understanding this process opens new possibilities for stopping Alzheimer’s progression by targeting how tau is transmitted.

...